FDA Investigator Amy L Singer

Amy L Singer has inspections in 2 countries as of 14 Sep 2023. Amy L Singer has collaborated with a combinined 3779 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
135
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Allen Lou, Amy M Codella, Amy M Cramer, Ana S Cabrera, Andrew J Molesky, Ankur C Patel, Ann Marie Montemurro, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony M Criscuolo, Jr, Antoinette L Ravelli, Atul J Agrawal, Barbara J Maulfair, Barbara J Maulfar, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Byungja E Marciante, Cara M Minelli, Cary Greene, Cassandra L Abellard, Charles J Chacko, Charles M Edwards, Charlotte P Chang, Chiang Syin, PhD, Christina N Maurino, Christine M Cerenzio, Colin E Tack, Craig W Swanson, Daniel J Grabicki, David H Smith, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Devon Jenkins, Dhaval H Patel, Donald L Lech, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edward Oshaughnessy, Elaine E Gilfillan, Emest F Bizjak, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Ernie F Bizkaj, Esteban Beltran, Frank J Marciniak, Fred Razzaghi, Frederick Razzaghi, George Pyramides, Gianine E Delade, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, Jacqueline Mdiaz Albertini, James R Birkenstamm, Janet A Rajan, Jason Kwong, Jay B Shah, Jean Blackston Hill, Jean Blackstone Hill, Jean M Kelahan, Jeffrey J Ebersole, Jennifer Macmillan, Jessica M Monteiro, Jessica S Estriplet, Jo Annc Declement, Joanne Heim, Jogy George, Jonathan S Helfgott, Jonee J Mearns, Jose M Cayuela, Joseph Duca, Joseph F Mcginnis, RPh, Josh Renzon Ramilo, Jot R Klena, Joy Rkozlowski Klena, Juanita P Versace, Justin A Boyd, Justine Tomasso, Karen A Spencer, Karen E D'orazio, Keith M Reilly, Kelli F Dobilas, Kelli F Regeny, Kelli F Regenye, Kelli Regente, Kenneth M Gordon, Kerry A Kurdilla, Kevin Obrien, Kevin P Foley, King, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Krystal O Ogunremi, Kyle D Covill, Laishan L Lam, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Lawrence Harmon, Jr, Lawrence R Johnson, Lenahan Lenahan, Peter R, Leticia S Jones, Li Li, Liatte Kreuger, PharmD, Lisa B Hall, Lisa Mathew, Loretta Nemchik, Luis A Dasta, Marcelo O Mangalindan, Jr, Marcia D Fields, Marea K Harmon, Margaret M Sands, Maria Estrella, Marjorie D Schultz, Melba T Rivera, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael Gurbarg, Michael R Klapal, Michael Serrano, Michelle M Parisi, Mielziner, Monika Borkowska, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj Mehta, Odera I Ekwunife, Patrick C Klotzbuecher, Paul L Bellamy, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Raymond L Cheung, Rebecca Rodriguez, Regina T Brown, Remache, Richard D Manney, Richard E Needham, Richard J Muzeni, Robert D Tollefsen, Robert G Ruff, Robin P Mathew, Rose Ljean Mary, Rose Xu, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Samir C Gala, Sandra Kershaw, Sarah Adella Fave, Sarah Forney, Satheesh K Podaralla, Sayyem H Akbar, Schultz, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Sinai Davis, State Agency, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Susan M Halsted, Susant Hadman, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Teigan M Mule, Thomas J Arista, Thomas M Herbst, Tonia F Bernard, Toyin B Oladimeji, Tyanna N Hadley, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Wayne J Meyer, William Chang, William J Leonard, William J Muszynski, William R Chang, Willy A Orantes, Xiaohan Cai, PhD, Yangmin Ning, Yasmin B Rios, Ying Zhang, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Amy L Singer's Documents

Publish Date Document Type Title
May, 2002 EIR OHM LABORATORIES INC. - EIR, 2002-05-06
April, 2001 EIR CP Packaging Inc - EIR, 2001-04-12
April, 2002 FDA 483 Church & Dwight Co., Inc. - Form 483, 2002-04-16
September, 2000 EIR Inopak Ltd - EIR, 2000-09-26
May, 2001 FDA 483 Fisher Scientific Co., LLC - Form 483, 2001-05-25
February, 2002 FDA 483 Tevco Enterprises, Inc. - Form 483, 2002-02-27
March, 2000 FDA 483 Cyalume Specialty Products - Form 483, 2000-03-16
October, 2003 EIR Bennett Testing Service, Inc - EIR, 2003-10-29
January, 2001 FDA 483 Hoffmann-La Roche Inc. - Form 483, 2001-01-31
March, 2001 FDA 483 Response OHM LABORATORIES INC. - Form 483R, 2001-04-02
December, 2001 EIR Hoffmann La Roche Inc - EIR, 2001-12-12
December, 2003 EIR E.M. Sergeant Pulp & Chemical Co, Inc - EIR, 2003-12-22
May, 2001 FDA 483 Response Pharmaceutical Formulations Inc. - Form 483R, 2001-05-29
June, 2003 FDA 483 Response Organon USA Inc. - Form 483R, 2003-06-27
June, 2003 EIR Organon USA Inc. - EIR, 2003-06-27
May, 2001 FDA 483 Pharmaceutical Formulations Inc. - Form 483, 2001-05-10
November, 2003 FDA 483 Ranbaxy Inc. - Form 483, 2003-11-17
April, 2002 EIR Medpointe Healthcare, Inc. - EIR, 2002-04-16
January, 2005 EIR Ohm Laboratories Inc. - EIR, 2005-01-18
February, 2000 FDA 483 P.E.L. Associates Inc - Form 483, 2000-02-15
May, 2000 FDA 483 Scientech Laboratories, Inc. - Form 483, 2000-05-24
March, 2001 EIR OHM LABORATORIES INC. - EIR, 2001-03-15
July, 2001 EIR Janssen Pharmaceuticals, Inc. - EIR, 2001-07-31
March, 2000 EIR Cyalume Specialty Products - EIR, 2000-03-16
October, 2003 EIR Laboratory Service Inc. - EIR, 2003-10-29
January, 2005 FDA 483 Response Ohm Laboratories Inc. - Form 483R, 2005-02-01
September, 2000 EIR CMIC CMO USA CORP - EIR, 2000-09-06
August, 2000 FDA 483 Sonar Products, Inc. - Form 483, 2000-08-14
November, 2003 FDA 483 Response Ranbaxy Inc. - Form 483R, 2003-12-04
September, 2003 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2003-09-30
September, 2000 FDA 483 INOPAK LTD. - Form 483, 2000-09-26
January, 2000 FDA 483 Advanced Care Products - Form 483, 2000-01-11
May, 2002 FDA 483 Response OHM LABORATORIES INC. - Form 483R, 2002-05-24
May, 2000 FDA 483 Response Scientech Laboratories, Inc. - Form 483R, 2000-07-11
June, 2002 FDA 483 Medpointe Healthcare, Inc. - Form 483, 2002-06-06
March, 2003 EIR Everest Life Sciences LLC - EIR, 2003-03-17
October, 2003 FDA 483 Laboratory Service Inc. - Form 483, 2003-10-29
September, 2003 EIR Hoffmann La Roche Inc - EIR, 2003-09-10
December, 2001 FDA 483 Hoffmann La Roche Inc - Form 483, 2001-12-12
October, 2003 EIR Bayer Healthcare, LLC - EIR, 2003-10-24
July, 2004 EIR Aeropharm Technology, LLC - EIR, 2004-07-23
May, 2001 EIR Pharmaceutical Formulations Inc. - EIR, 2001-05-10
February, 2002 FDA 483 Bayer HealthCare LLC - Form 483, 2002-02-04
May, 2001 EIR Fisher Scientific Co., LLC - EIR, 2001-05-25
April, 2004 FDA 483 Guardian Drug Company - Form 483, 2004-04-23
June, 2002 FDA 483 Response Medpointe Healthcare, Inc. - Form 483R, 2002-06-25
November, 2004 FDA 483 Response Ohm Laboratories Inc - Form 483R, 2004-11-22
June, 2002 EIR Medpointe Healthcare, Inc. - EIR, 2002-06-06
April, 2001 FDA 483 CP Packaging Inc - Form 483, 2001-04-12
September, 2000 FDA 483 CMIC CMO USA CORP - Form 483, 2000-09-06
January, 2001 EIR Hoffmann La Roche Inc - EIR, 2001-01-31
March, 2001 FDA 483 OHM LABORATORIES INC. - Form 483, 2001-03-15
June, 2003 FDA 483 Organon USA Inc. - Form 483, 2003-06-27
November, 2003 EIR Ranbaxy Inc. - EIR, 2003-11-17
September, 2003 EIR Daiichi Sankyo, Inc. - EIR, 2003-09-23
August, 2001 EIR Vantage Specialty Ingredients, Inc - EIR, 2001-08-09
July, 2000 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2000-07-20
May, 2002 EIR Ohm Laboratories, Inc. - EIR, 2002-05-16
July, 2001 FDA 483 Intertek USA, Inc. - Form 483, 2001-07-25
November, 2004 EIR Ohm Laboratories Inc - EIR, 2004-11-22
February, 2000 EIR Xechem Inc - EIR, 2000-02-17
December, 2003 FDA 483 E.M. Sergeant Pulp & Chemical Co, Inc - Form 483, 2003-12-22
August, 2001 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2001-08-09
April, 2001 FDA 483 Response CP Packaging Inc - Form 483R, 2001-04-19
July, 2001 FDA 483 Janssen Pharmaceuticals, Inc. - Form 483, 2001-07-31
May, 2002 FDA 483 OHM LABORATORIES INC. - Form 483, 2002-05-06
October, 2001 EIR Vantage Specialty Ingredients, Inc - EIR, 2001-10-02
November, 2003 EIR Medicos Labs, Inc. - EIR, 2003-11-07
January, 2001 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2001-02-21
December, 2003 EIR Qualchem Corp - EIR, 2003-12-03
November, 2004 FDA 483 Ohm Laboratories Inc - Form 483, 2004-11-22
December, 2003 FDA 483 Qualtech Laboratories, Inc. - Form 483, 2003-12-16
November, 2004 EIR OHM LABORATORIES INC. - EIR, 2004-11-23
September, 2003 FDA 483 Hoffmann La Roche Inc - Form 483, 2003-09-10
December, 2003 EIR Qualtech Laboratories, Inc. - EIR, 2003-12-15
December, 2004 FDA 483 Medico Labs, Inc. - Form 483, 2004-12-23
June, 2000 EIR Air Products and Chemicals, Inc. - EIR, 2000-06-01

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more